Gilead Sciences Inc. (GILD)

Gilead Sciences Inc. (GILD $113.10)
- $113.10 P/E (TTM): 22.04X Cap: $139.29B
- View GILD Profile
- View Questions on GILD

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $275.10)
- $275.10 P/E (TTM): 22.31X Cap: $147.89B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $113.10)
- $113.10 P/E (TTM): 22.04X Cap: $139.29B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $220.79)
- $220.79 P/E (TTM): 103.47X Cap: $382.03B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $132.54)
- $132.54 P/E (TTM): 16.66X Cap: $233.51B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $294.72)
- $294.72 P/E (TTM): 16.17X Cap: $79.16B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $175.70)
- $175.70 P/E (TTM): 18.87X Cap: $426.75B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $94.47)
- $94.47 P/E (TTM): 26.09X Cap: $121.31B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $20.91)
- $20.91 P/E (TTM): 26.77X Cap: $1.48B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025

Gilead Sciences Inc. (GILD $113.10)
- $113.10 P/E (TTM): 22.04X Cap: $139.29B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $433.60)
- $433.60 P/E (TTM): 60.52X Cap: $155.45B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $220.79)
- $220.79 P/E (TTM): 103.47X Cap: $382.03B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $175.70)
- $175.70 P/E (TTM): 18.87X Cap: $426.75B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $766.38)
- $766.38 P/E (TTM): 49.98X Cap: $719.43B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $94.47)
- $94.47 P/E (TTM): 26.09X Cap: $121.31B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $375.52)
- $375.52 P/E (TTM): 49.88X Cap: $144.08B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $476.74)
- $476.74 P/E (TTM): 27.8X Cap: $178.47B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $137.30)
- $137.30 P/E (TTM): 23.54X Cap: $34.32B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $60.04)
- $60.04 P/E (TTM): 28.17X Cap: $4.18B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $18.77)
- $18.77 P/E (TTM): 24.51X Cap: $4.56B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $18.22)
- $18.22 Cap: $6.44B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $70.56)
- $70.56 P/E (TTM): 19.22X Cap: $577M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $20.11)
- $20.11 P/E (TTM): 12.16X Cap: $2.45B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025

Gilead Sciences Inc. (GILD $113.10)
- $113.10 P/E (TTM): 22.04X Cap: $139.29B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $433.60)
- $433.60 P/E (TTM): 60.52X Cap: $155.45B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $220.79)
- $220.79 P/E (TTM): 103.47X Cap: $382.03B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $766.38)
- $766.38 P/E (TTM): 49.98X Cap: $719.43B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $375.52)
- $375.52 P/E (TTM): 49.88X Cap: $144.08B
- View SYK Profile
- View Questions on SYK
Harvest Healthcare Leaders Income ETF (HHL $7.17)
- $7.17 P/E (TTM): 72.11X Cap: $1.40B
- View HHL Profile
- View Questions on HHL
Catalyst Pharmaceuticals Inc. (CPRX $20.11)
- $20.11 P/E (TTM): 12.16X Cap: $2.45B
- View CPRX Profile
- View Questions on CPRX

Q: Seems the whole Healthcare sector stocks are depressed right now. Aside from ISRG (owned) which five are the most compelling to own and at what entry price are they wotth it? Canadian would be best, or ADRs. But I'll take US or world suggestions also.
Thank you!

Read Answer Asked by Roger on June 27, 2025